ANIK (STOCKS)
Anika Therapeutics Inc
$21.170000
-0.860000 (-3.90%)
Prev close: $22.030000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Stephen D. Griffin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $301.22M
- Employees
- 288
- P/E (TTM)
- -80.40
- P/B (TTM)
- 2.15
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $120.65M |
| Benefits Costs and Expenses | $123.57M |
| Cost Of Revenue | $45.65M |
| Costs And Expenses | $80.13M |
| Gross Profit | $75.00M |
| Operating Expenses | $80.13M |
| Selling, General, and Administrative Expenses | $52.67M |
| Depreciation and Amortization | $5.62M |
| Research and Development | $27.45M |
| Operating Income/Loss | -$5.12M |
| Income/Loss From Continuing Operations After Tax | -$3.12M |
| Income/Loss From Continuing Operations Before Tax | -$2.91M |
| Income/Loss From Discontinued Operations Net Of Tax | -$663.00K |
| Income Tax Expense/Benefit | $208.00K |
| Income Tax Expense/Benefit, Deferred | $215.00K |
| Net Income/Loss | -$3.78M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$3.78M |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.78M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.27 |
| Diluted Earnings Per Share | -$0.27 |
| Basic Average Shares | 27,827,000 |
| Diluted Average Shares | 27,827,000 |
| Assets | $183.47M |
| Current Assets | $99.19M |
| Inventory | $28.57M |
| Other Current Assets | $70.63M |
| Noncurrent Assets | $84.28M |
| Fixed Assets | $40.10M |
| Intangible Assets | $1.65M |
| Other Non-current Assets | $42.53M |
| Liabilities | $46.19M |
| Current Liabilities | $22.15M |
| Accounts Payable | $6.24M |
| Wages | $7.54M |
| Other Current Liabilities | $8.38M |
| Noncurrent Liabilities | $24.05M |
| Equity | $137.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $137.28M |
| Liabilities And Equity | $183.47M |
| Net Cash Flow From Operating Activities | $5.98M |
| Net Cash Flow From Operating Activities, Continuing | $5.98M |
| Net Cash Flow From Investing Activities | -$4.05M |
| Net Cash Flow From Investing Activities, Continuing | -$4.05M |
| Net Cash Flow From Financing Activities | -$16.34M |
| Net Cash Flow From Financing Activities, Continuing | -$16.34M |
| Net Cash Flow | -$14.42M |
| Net Cash Flow, Continuing | -$14.42M |
| Comprehensive Income/Loss | -$4.36M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$4.36M |
| Other Comprehensive Income/Loss | $8.85M |